Search for: "Merck & Co., Inc. "
Results 341 - 360
of 664
Sort by Relevance
|
Sort by Date
20 Jan 2011, 12:50 pm
Merck & Co., 2003 WL 21658613, at *5 (Ohio App. [read post]
18 Jan 2011, 3:10 am
See, e.g., Merck & Co., Inc. v. [read post]
15 Dec 2010, 2:17 am
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not… [read post]
4 Dec 2010, 5:00 am
The court directed Plaintiffs to address Merck & Co. [read post]
15 Nov 2010, 2:12 pm
Now, in November 2010, the FDA has approved a Supplemental New Drug Application (sNDA) submitted June 16, 2010 by Merck & Co., Inc. -- under section 505(b) of the Federal Food, Drug, and Cosmetic Act (FDCA) -- adding interstitial lung disease (ILD) to the "ADVERSE REACTIONS, Post-Marketing Experience, subsection of the Zocor package insert", or label. [read post]
11 Nov 2010, 12:54 pm
Merck & Co., 2003 WL 22902622, at *3 n.3 (E.D. [read post]
2 Nov 2010, 11:00 am
Merck & Co., Inc. [read post]
2 Nov 2010, 10:26 am
” Merck & Co., Inc. v. [read post]
1 Nov 2010, 2:46 am
Staples, Inc. [read post]
27 Oct 2010, 4:07 am
Merck & Co., Inc., No. 10 C 1297, Slip Op. [read post]
30 Sep 2010, 1:18 pm
Merck & Co., Inc. [read post]
28 Sep 2010, 6:46 am
Logan, 38 F.Supp.2d 463 (W.D.Va.1999) (civil rights action); see also In re Merck Prods. [read post]
13 Sep 2010, 3:12 pm
Co. v. [read post]
1 Sep 2010, 4:14 am
"They have a very large product line," he says.However, in view of the product lines which have been implicated, the problem of false marking is a bit more complicated:Defendants include companies such as Procter & Gamble, Bayer Healthcare LLC, Cisco Systems, Scientific-Atlanta, Merck & Co., Pfizer Inc., 3M Co., DirecTV, Medtronic Inc. [read post]
31 Aug 2010, 10:01 pm
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
27 Aug 2010, 2:41 pm
” Summary judgment affirmed.American Tobacco Co., Inc. v. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
9 Aug 2010, 10:14 pm
See Monsanto Co. v. [read post]
9 Aug 2010, 2:33 pm
The recent 10-Q filing of Merck & Co., Inc. stated in part: The Company has received letters from the DOJ and the SEC that seek information about activities in a number of countries and reference the Foreign Corrupt Practices Act. [read post]
5 Aug 2010, 2:08 pm
Wyeth Laboratories, Inc., 533 N.E.2d 748 (Ohio 1988) (the Ohio Supreme Court rejecting the theory). [read post]
